dronabinol has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bromley-Brits, K; Cai, F; Chen, B; He, G; Song, W; Zhang, X | 1 |
| Blázquez, C; de Ceballos, ML; Gómez del Pulgar, T; Guzmán, M; Ramírez, BG | 1 |
2 other study(ies) available for dronabinol and Amyloid Deposits
| Article | Year |
|---|---|
Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Female; Humans; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Treatment Failure | 2010 |
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzoxazines; Cannabinoids; Cells, Cultured; Coculture Techniques; Dronabinol; Female; Humans; Injections, Intraventricular; Male; Maze Learning; Microglia; Middle Aged; Morpholines; Motor Activity; Naphthalenes; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide; Peptide Fragments; Plaque, Amyloid; Protein Processing, Post-Translational; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Tumor Necrosis Factor-alpha | 2005 |